Skip to main content
Clinical Trials/NCT01761734
NCT01761734
Completed
Not Applicable

Pilot Study of Text Message Reminders for Flu Vaccine For Adults

Columbia University1 site in 1 country1,000 target enrollmentJanuary 2013
ConditionsInfluenza

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza
Sponsor
Columbia University
Enrollment
1000
Locations
1
Primary Endpoint
Receipt of an influenza vaccine dose
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in racial/ethnic minority groups. In order to address the problem of low influenza vaccination rates in minority adults, we plan to build on the well-accepted practice of immunization recall-reminders and the emerging practice of using text message to pilot the feasibility of using text messaging to improve influenza vaccination coverage rates in a low health literacy, largely minority, publicly insured adult population.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
May 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Melissa Stockwell, MD, MPH

Assistant Professor of Pediatrics and Population and Family Health

Columbia University

Eligibility Criteria

Inclusion Criteria

  • \> or = 18 years of age,
  • at least one visit to the AIM clinic during the previous year
  • a cell phone number in the registration system
  • fluent in English or Spanish. Exclusion criteria

Exclusion Criteria

  • Receipt of influenza vaccination during the 2012-2013 influenza season prior to randomization.

Outcomes

Primary Outcomes

Receipt of an influenza vaccine dose

Time Frame: March 31, 2013

Proportion of individuals in each group receiving an influenza dose by the end of the influenza season

Study Sites (1)

Loading locations...

Similar Trials